Shunzhong Gu

发表论文 2 篇

代表论文

• Tetramethylpyrazine regulating FNDC5 through PI3K/AKT pathway in the treatment of acute myocardial ischemic injury (2026 · SSRN Electronic Journal)
• Ivermectin Derivatives: A Pivotal Anti COVID-19 Drug Molecules Blocking the Manifestation of Coronavirus (2021 · Tobacco Regulatory Science)